en · de · es · fr · pt
faq-desk.peptides7250.com › Info › Background And Molecular Features — Practical Notes

Background And Molecular Features — Practical Notes

By Editorial Desk · published 2025-11-18 · last reviewed 2025-12-08 · Info

GHRH analog comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2025-12-08. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Molecular Features

Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.

The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.

Mechanism and Pharmacokinetics

Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.

The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.

Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.

Cjc-1295 at a glance

PropertyValueNotes
ClassSynthetic peptideGHRH receptor agonist
Sequence length29 amino acidsDerived from human GHRH
Molecular weightAbout 3368 Da without linkerAlbumin-binding form is heavier
AppearanceWhite to off-white lyophilized powderCommon form for research reference material
Typical storage-20 °C or below, desiccatedProtect powder from light and moisture

Identity and Naming History

The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.

Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.

CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.

Related pages on this site

Albumin Binding and Duration of Action

The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.

Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.

Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.

Reference notes

Teresa is portrayed by Chie Tanaka (田中 千絵, Tanaka Chie). Falufian Yaako (ファルファ星人ヤーコ, Farufa Seijin Yāko): A small pig-themed alien child from Planet Faluf who is capable of manipulating locks. Due to this, she was kidnapped by an Alienizer named Gyanjava, who killed her parents and forced her to aid him in bank robberies across the galaxy. Amidst Gyanjava's attempt to access the Deka Base's systems, Yaako escaped from him and came to S.P.D. to stop him. While under Ban's protection, she transforms into her winged-adult form before using her powers to remove Gyanjava's armor so Ban can delete him. Following this, Yaako continues to help S.P.D. Yaako is voiced by Shoko Nakagawa (中川 翔子, Nakagawa Shōko), who also portrays her adult form. Miwa Tomasu (戸増 美和, Tomasu Miwa): Hoji's younger sister who also blurts out English phrases when she gets upset. Miwa Tomasu is portrayed by Kaori Ikeda (池田 香織, Ikeda Kaori). Space Life Form Browgoul (宇宙生物ブラウゴール, Uchū Seibutsu Buraugōru): Monstrous alien beasts that feed on the metal of meteors to increase in size. An Alienizer named Nikaradar brings two of the beasts to Earth, where he feeds on the corpse of a professor he killed whose form he assumes in order to direct a meteor to Earth. Though the first Browgoul is killed by Super Dekaranger Robo, its power is transferred to its recently hatched younger sibling, who overpowers Super Dekaranger Robo before willing the meteor back on its course to Earth. With Nikaradar having been deleted, Abrella intends to breed the second Browgoul himself, following Earth's destruction.

A mendelian randomization trial in humans found that a 1-standard deviation increase in genetically proxied LDL-C levels was associated with 1.2 years lower lifespan. This presents with an interesting candidate for increasing life span in select populations with such potentially deleterious mutations, since atherosclerosis is one of the leading causes of mortality through causing potentially fatal atherosclerotic cardiovascular disease. Considering many LDL-C lowering drugs are already approved to reduce mortality in select populations, there is certainly not a paucity of research.

=== Radiology === Recent radiologic appraisals of the mesenteric organ have been conducted in the context of the contemporary understanding of mesenteric organ anatomy. When this organ is divided into non-flexural and flexural regions, these can readily be differentiated in most patients on CT imaging. Clarification of the radiological appearance of the human mesentery resonates with the suggestions of Dodds and enables a clearer conceptualization of mesenteric derangements in disease states. This is of immediate relevance in the spread of cancer from colon cancer and perforated diverticular disease, and in pancreatitis where fluid collections in the lesser sac dissect the mesocolon from the retroperitoneum and thereby extend distally within the latter.

Sources: en.wikipedia.org

Notes from published material

The British troops had antiquated tactics—and in some cases antiquated weapons—against the mobile Boer forces with the destructive fire of their modern Mausers, the latest Krupp field guns and their novel tactics. On 7 December, a raid at Enslin Station further highlighted British weaknesses, notably their supply line, which was vulnerable to guerrilla attacks. The middle of December was disastrous for the British. In a period known as Black Week (10–15 December 1899), the British suffered defeats on three fronts. On 10 December, General Gatacre tried to recapture Stormberg railway junction about 80 kilometres (50 mi) south of the Orange River. Gatacre's attack was marked by administrative and tactical blunders and the Battle of Stormberg ended in a British defeat, with 135 killed and wounded and two guns and over 600 troops captured. At the Battle of Magersfontein on 11 December, Methuen's 14,000 British troops attempted to capture a Boer position in a dawn attack to relieve Kimberley. This too turned into a disaster when the Highland Brigade became pinned down by accurate Boer fire. After suffering from intense heat and thirst for nine hours, they eventually broke in ill-disciplined retreat. The Boer commanders, Koos de la Rey and Cronjé, had ordered trenches to be dug in an unconventional place to fool the British and give their riflemen a greater firing range. The plan worked, and this tactic helped to write the doctrine of the supremacy of the defensive position, using modern small arms and trench fortifications.

=== Patents === According to the World Health Organization (WHO), the biggest barrier to vaccine production in less developed countries has not been patents, but the substantial financial, infrastructure, and workforce requirements needed for market entry. Vaccines are complex mixtures of biological compounds, and unlike the case for prescription drugs, there are no true generic vaccines. The vaccine produced by a new facility must undergo complete clinical testing for safety and efficacy by the manufacturer. For most vaccines, specific processes in technology are patented. These can be circumvented by alternative manufacturing methods, but this required R&D infrastructure and a suitably skilled workforce. In the case of a few relatively new vaccines, such as the human papillomavirus vaccine, the patents may impose an additional barrier. When increased production of vaccines was urgently needed during the COVID-19 pandemic in 2021, the World Trade Organization and governments around the world evaluated whether to waive intellectual property rights and patents on COVID-19 vaccines, which would "eliminate all potential barriers to the timely access of affordable COVID-19 medical products, including vaccines and medicines, and scale up the manufacturing and supply of essential medical products".

=== Chinese majors === On 16 September, the AQSIQ released test of samples from 491 batches of products sold by all 109 companies producing baby formula. It said all 11 samples from Sanlu failed the melamine test. Sanlu, whose products sell at half the price of equivalents on the market, recorded the highest levels of contamination among all the samples tested, at 2,563 mg/kg or parts per million ("ppm"). Tainted samples were found among 21 other suppliers, where concentrations ranged from 0.09 to 619.00 ppm. There was melamine contamination in 10% of liquid milk samples from Mengniu and Yili, and 6% of those from Bright Dairy. On discovery of contamination, the three major producers were all stripped of their status as 'Chinese national brands'. Yili, Mengniu and Bright Dairy & Food Co. recalled tainted powdered milk and apologised in separate statements. Mengniu recalled all its baby formula, and trading in its shares on the Hong Kong Stock Exchange was suspended on 17 September. Shares in other dairy companies fell strongly the next day. Mengniu's CFO attempted to reassure consumers by offering a no-quibble refund on all products, and by drinking liquid milk in front of reporters in Hong Kong. He also said that its export products were less likely to be contaminated. On 30 September, the AQSIQ announced test results of a further 265 batches of powdered milk produced by 154 different companies prior to 14 September, where it found 31 batches produced by 20 domestic dairy companies were tainted with melamine.

==== Film and television ==== In season 7 episode 12 of the series House, M.D. is about a patient who has a temporary paralysis and creatine kinase. She has a "perfect memory" due to her hyperthymesia. It later concludes her hyperthymesia is the way her OCD presents and that taking SSRI to treat her OCD will dial down her hyperthymesia. In the 2014 film The Dark Place, the protagonist of the story, Keegan Dark, has hyperthymesia. Keegan uses it to solve the mystery at the heart of the story. His hyperthymesia memories are visually depicted in the movie as "screens" appearing to Keegan, often in an overwhelming and distressing manner. In season 2 episode 2 of the TV show The Blacklist a character involved in criminal banking enterprises identified herself as having hyperthymesia as a skillful trait to avoid leaving a paper trail for illegal activities. She provided the FBI agents in the episode with real examples by recitation of events of dates selected at random. Her skills seemed to be date oriented rather than triggered by "personal experience." Unforgettable (American TV series) The 2015 South Korean TV series Remember: War of the Son portrays a hyperthymestic lawyer who sought to prove the innocence of his father, who had been convicted and sentenced to death for the brutal rape-murder of a neighbour. The 2020 South Korean TV series Find Me in Your Memory portrays the love story between a hyperthymestic news anchorman and an actress with amnesia, connected by a past traumatic event.

Sources: en.wikipedia.org

Frequently asked questions

What is the difference between CJC-1295 and natural GHRH?

Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.

Why does one name cover two different peptides?

The label was first attached to the albumin-binding form during early development work. A shorter analog without the linker later became known by the same name in informal use. Published papers normally state which version was studied, so the methods section resolves the ambiguity.

Is CJC-1295 a steroid or a natural hormone?

It is a synthetic peptide rather than a steroid, and it does not occur naturally in the body. Its sequence is derived from a hypothalamic hormone called growth hormone-releasing hormone. It works as a receptor agonist rather than as a replacement for that hormone.

How long does the albumin-binding form remain active?

Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.

Network